Angiogenin, belonging to the ribonuclease A family, has been reported to enhance angiogenesis and metastatic progression in bladder cancer through the activation of critical downstream elements within the PI3K–AKT–mTOR pathway (40). This evidence concerns the gene AKT1 and urinary bladder carcinoma.